<p>TMAs were scored by a certified pathologist for intensity and extent of staining. (A and B) Distribution of maximum TAP1 and TAP2 quick scores, respectively, among individual breast cancer tumor specimens. (C-F) TAP1-stained TMA cores from breast tumor specimens. (C) Grade 3 invasive ductal carcinoma: 0 intensity × 0% extent. (D) Grade 3 invasive ductal carcinoma: 1 intensity × 80% extent. (E) Grade 2 invasive ductal carcinoma: 2 intensity × 60% extent. (F) Grade 3 invasive ductal carcinoma: 3 intensity × 90% extent. (G-J) represents TAP2-stained TMA cores from breast tumor specimens. (G) Grade 2 invasive lobular carcinoma: 0 intensity × 0% extent. (H) Grade 3 invasive ductal carcinoma: 1 intensity × 80% extent. (I) Grade 3 invasive duct...
Background: Tissue microarrays (TMAs) are an attractive alternative to analysis of whole sections (W...
Aims: To compare visual and computerized image analysis of HER2 immunohistochemistry (IHC) with fluo...
Tumor cell proliferation in breast cancer is strongly prognostic and may also predict response to ch...
<p>TMAs comprised of 131 breast cancer tumors of different subtypes from patients with classified br...
Tissue microarray (TMA) is an efficient technique for analysis of molecular markers. Prospectively c...
<p>(<b>A and B</b>) <i>RNA and protein levels of TTK in human breast cancers from omic data selected...
BACKGROUNDAnalysis of immunohistochemical expression of a large number of tumor tissue samples with ...
Breast cancers today are of predominantly T1 (0.1 ≥ 2.0 cm) or T2 (>2 ≤ 5 cm) categories due to earl...
BACKGROUND: High-throughput evaluation of tissue biomarkers in oncology has been greatly accelerated...
Introduction: Tumor cell proliferation in breast cancer is strongly prognostic and may also predict ...
<p>A and B, COUP-TFII immunostaining at 200×: A, benign breast tissue (H-score 30) and B, invasive d...
<p>(A) The diagram presents immunohistochemical profiles of ADCIS, IACs and invasive ductal carcinom...
<p>Representative photomicrographs of TRα and TRβ immunohistochemistry staining in breast cancer tis...
BackgroundTissue microarrays (TMAs) have become a valuable resource for biomarker expression in tran...
Many breast cancers today, nearly 80%, are invasive. When a tumor becomes invasive, it has spread pa...
Background: Tissue microarrays (TMAs) are an attractive alternative to analysis of whole sections (W...
Aims: To compare visual and computerized image analysis of HER2 immunohistochemistry (IHC) with fluo...
Tumor cell proliferation in breast cancer is strongly prognostic and may also predict response to ch...
<p>TMAs comprised of 131 breast cancer tumors of different subtypes from patients with classified br...
Tissue microarray (TMA) is an efficient technique for analysis of molecular markers. Prospectively c...
<p>(<b>A and B</b>) <i>RNA and protein levels of TTK in human breast cancers from omic data selected...
BACKGROUNDAnalysis of immunohistochemical expression of a large number of tumor tissue samples with ...
Breast cancers today are of predominantly T1 (0.1 ≥ 2.0 cm) or T2 (>2 ≤ 5 cm) categories due to earl...
BACKGROUND: High-throughput evaluation of tissue biomarkers in oncology has been greatly accelerated...
Introduction: Tumor cell proliferation in breast cancer is strongly prognostic and may also predict ...
<p>A and B, COUP-TFII immunostaining at 200×: A, benign breast tissue (H-score 30) and B, invasive d...
<p>(A) The diagram presents immunohistochemical profiles of ADCIS, IACs and invasive ductal carcinom...
<p>Representative photomicrographs of TRα and TRβ immunohistochemistry staining in breast cancer tis...
BackgroundTissue microarrays (TMAs) have become a valuable resource for biomarker expression in tran...
Many breast cancers today, nearly 80%, are invasive. When a tumor becomes invasive, it has spread pa...
Background: Tissue microarrays (TMAs) are an attractive alternative to analysis of whole sections (W...
Aims: To compare visual and computerized image analysis of HER2 immunohistochemistry (IHC) with fluo...
Tumor cell proliferation in breast cancer is strongly prognostic and may also predict response to ch...